FIU990494U0 - Uusi koostumus - Google Patents

Uusi koostumus

Info

Publication number
FIU990494U0
FIU990494U0 FI990494U FIU990494U FIU990494U0 FI U990494 U0 FIU990494 U0 FI U990494U0 FI 990494 U FI990494 U FI 990494U FI U990494 U FIU990494 U FI U990494U FI U990494 U0 FIU990494 U0 FI U990494U0
Authority
FI
Finland
Prior art keywords
new composition
composition
new
Prior art date
Application number
FI990494U
Other languages
English (en)
Swedish (sv)
Inventor
David Philip Elder
Deeb Al Ahmad Khalaf Al
Meneaud Padma
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FIU990494U0 publication Critical patent/FIU990494U0/fi
Application granted granted Critical
Publication of FI4488U1 publication Critical patent/FI4488U1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI990494U 1999-06-22 1999-12-03 Farmaseuttinen koostumus FI4488U1 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
FIU990494U0 true FIU990494U0 (fi) 1999-12-03
FI4488U1 FI4488U1 (fi) 2000-07-20

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
FI992609A FI19992609A (fi) 1999-06-22 1999-12-03 Uusi koostumus
FI990494U FI4488U1 (fi) 1999-06-22 1999-12-03 Farmaseuttinen koostumus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI992609A FI19992609A (fi) 1999-06-22 1999-12-03 Uusi koostumus

Country Status (21)

Country Link
EP (1) EP1064936A1 (fi)
AT (1) AT3722U1 (fi)
AU (2) AU1573100A (fi)
BE (2) BE1013166A6 (fi)
CA (1) CA2291542A1 (fi)
CH (1) CH690024A5 (fi)
DE (2) DE29921300U1 (fi)
DK (2) DK199900435U3 (fi)
ES (1) ES2159260B1 (fi)
FI (2) FI19992609A (fi)
FR (1) FR2795327A1 (fi)
GB (1) GB2351233A (fi)
GR (1) GR1003490B (fi)
IE (2) IES991108A2 (fi)
IT (1) ITMI992549A1 (fi)
LU (1) LU90483B1 (fi)
NL (2) NL1013750C1 (fi)
NO (1) NO995945L (fi)
PT (1) PT102384A (fi)
SE (1) SE9904404L (fi)
WO (1) WO2000078291A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (en) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
AU2001284322A1 (en) 2000-08-29 2002-03-13 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
JP2005517690A (ja) 2002-02-01 2005-06-16 ファイザー・プロダクツ・インク 固体薬物分散物を含有する即時放出剤形
EP1660496A1 (en) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
CA2291542A1 (en) 2000-12-22
SE9904404L (sv) 2000-12-23
GR1003490B (el) 2000-11-30
ES2159260B1 (es) 2002-05-01
BE1013166A6 (fr) 2001-10-02
GB2351233A (en) 2000-12-27
FR2795327A1 (fr) 2000-12-29
WO2000078291A1 (en) 2000-12-28
LU90483B1 (fr) 2001-01-31
DK199900435U3 (da) 2000-02-11
ITMI992549A1 (it) 2001-06-03
NO995945D0 (no) 1999-12-03
DK199901730A (da) 2000-12-23
DE19958228A1 (de) 2000-12-28
CH690024A5 (fr) 2000-03-31
DE29921300U1 (de) 2000-02-10
FI4488U1 (fi) 2000-07-20
ITMI992549A0 (it) 1999-12-03
FI19992609A (fi) 2000-12-22
GB9928673D0 (en) 2000-02-02
IE991107A1 (en) 2001-05-30
PT102384A (pt) 2000-12-29
ES2159260A1 (es) 2001-09-16
IES991108A2 (en) 2001-04-04
EP1064936A1 (en) 2001-01-03
AU1573100A (en) 2001-01-09
SE9904404D0 (sv) 1999-12-03
AT3722U1 (de) 2000-07-25
NL1013750C1 (nl) 2000-12-28
AU727000B3 (en) 2000-11-30
NL1013749C2 (nl) 2001-01-08
NO995945L (no) 2000-12-27
BE1012806A3 (fr) 2001-03-06

Similar Documents

Publication Publication Date Title
NO20021116D0 (no) Ny sammensetning
IS6120A (is) Lyfjablanda
NO20021115D0 (no) Ny sammensetning
FI991485A0 (fi) Uusi farmaseuttinen koostumus
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
AR023440A1 (es) Composiciones antitranspirantes
ID29430A (id) Komposisi herbisida
ID29785A (id) Komposisi-komposisi sampo
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
DE69943245D1 (de) Gaserzeugende zusammensetzung
DK199901730A (da) Ny Sammensætning
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
ID26295A (id) Komposisi keras-ultraviolet
NO20005483D0 (no) Ny sammensetning
ID26485A (id) Komposisi paroksetina
ID27329A (id) Komposisi penghambat
NO20011313L (no) Ny sammensetning
NO20022845L (no) Limsammensetning
DE69939964D1 (de) Gelförmige Zusammensetzung
ID30320A (id) Komposisi-komposisi berpigmen
NO20011312L (no) Ny sammensetning
NO20021026L (no) Ny forbindelse F-15078